OBJECTIVE: Childhood maltreatment increases risk for psychopathology. For some highly prevalent disorders (major depression, substance abuse, anxiety disorders, and posttraumatic stress disorder) a substantial subset of individuals have a history of maltreatment and a substantial subset do not. The authors examined the evidence to assess whether those with a history of maltreatment represent a clinically and biologically distinct subtype. METHOD: The authors reviewed the literature on maltreatment as a risk factor for these disorders and on the clinical differences between individuals with and without a history of maltreatment who share the same diagnoses. Neurobiological findings in maltreated individuals were reviewed and compared with findings reported for these disorders. RESULTS: Maltreated individuals with depressive, anxiety, and substance use disorders have an earlier age at onset, greater symptom severity, more comorbidity, a greater risk for suicide, and poorer treatment response than nonmaltreated individuals with the same diagnoses. Imaging findings associated with these disorders, such as reduced hippocampal volume and amygdala hyperreactivity, are more consistently observed in maltreated individuals and may represent a maltreatment-related risk factor. Maltreated individuals also differ from others as a result of epigenetic modifications and genetic polymorphisms that interact with experience to increase risk for psychopathology. CONCLUSIONS: Phenotypic expression of psychopathology may be strongly influenced by exposure to maltreatment, leading to a constellation of ecophenotypes. While these ecophenotypes fit within conventional diagnostic boundaries, they likely represent distinct subtypes. Recognition of this distinction may be essential in determining the biological bases of these disorders. Treatment guidelines and algorithms may be enhanced if maltreated and nonmaltreated individuals with the same diagnostic labels are differentiated.
OBJECTIVE:Childhood maltreatment increases risk for psychopathology. For some highly prevalent disorders (major depression, substance abuse, anxiety disorders, and posttraumatic stress disorder) a substantial subset of individuals have a history of maltreatment and a substantial subset do not. The authors examined the evidence to assess whether those with a history of maltreatment represent a clinically and biologically distinct subtype. METHOD: The authors reviewed the literature on maltreatment as a risk factor for these disorders and on the clinical differences between individuals with and without a history of maltreatment who share the same diagnoses. Neurobiological findings in maltreated individuals were reviewed and compared with findings reported for these disorders. RESULTS: Maltreated individuals with depressive, anxiety, and substance use disorders have an earlier age at onset, greater symptom severity, more comorbidity, a greater risk for suicide, and poorer treatment response than nonmaltreated individuals with the same diagnoses. Imaging findings associated with these disorders, such as reduced hippocampal volume and amygdala hyperreactivity, are more consistently observed in maltreated individuals and may represent a maltreatment-related risk factor. Maltreated individuals also differ from others as a result of epigenetic modifications and genetic polymorphisms that interact with experience to increase risk for psychopathology. CONCLUSIONS: Phenotypic expression of psychopathology may be strongly influenced by exposure to maltreatment, leading to a constellation of ecophenotypes. While these ecophenotypes fit within conventional diagnostic boundaries, they likely represent distinct subtypes. Recognition of this distinction may be essential in determining the biological bases of these disorders. Treatment guidelines and algorithms may be enhanced if maltreated and nonmaltreated individuals with the same diagnostic labels are differentiated.
Authors: M J Lyons; S A Eisen; J Goldberg; W True; N Lin; J M Meyer; R Toomey; S V Faraone; M Merla-Ramos; M T Tsuang Journal: Arch Gen Psychiatry Date: 1998-05
Authors: L M Shin; R J McNally; S M Kosslyn; W L Thompson; S L Rauch; N M Alpert; L J Metzger; N B Lasko; S P Orr; R K Pitman Journal: Am J Psychiatry Date: 1999-04 Impact factor: 18.112
Authors: M D De Bellis; M S Keshavan; D B Clark; B J Casey; J N Giedd; A M Boring; K Frustaci; N D Ryan Journal: Biol Psychiatry Date: 1999-05-15 Impact factor: 13.382
Authors: Eric Vermetten; Christian Schmahl; Sanneke Lindner; Richard J Loewenstein; J Douglas Bremner Journal: Am J Psychiatry Date: 2006-04 Impact factor: 18.112
Authors: V J Felitti; R F Anda; D Nordenberg; D F Williamson; A M Spitz; V Edwards; M P Koss; J S Marks Journal: Am J Prev Med Date: 1998-05 Impact factor: 5.043
Authors: Nadine M Melhem; John G Keilp; Giovanna Porta; Maria A Oquendo; Ainsley Burke; Barbara Stanley; Thomas B Cooper; J John Mann; David A Brent Journal: Neuropsychopharmacology Date: 2015-10-09 Impact factor: 7.853
Authors: Alexandria Meyer; Greg Hajcak Proudfit; Sara J Bufferd; Autumn J Kujawa; Rebecca S Laptook; Dana C Torpey; Daniel N Klein Journal: J Abnorm Child Psychol Date: 2015-07
Authors: U Dannlowski; H J Grabe; K Wittfeld; J Klaus; C Konrad; D Grotegerd; R Redlich; T Suslow; N Opel; P Ohrmann; J Bauer; P Zwanzger; I Laeger; C Hohoff; V Arolt; W Heindel; M Deppe; K Domschke; K Hegenscheid; H Völzke; D Stacey; H Meyer Zu Schwabedissen; H Kugel; B T Baune Journal: Mol Psychiatry Date: 2014-04-29 Impact factor: 15.992
Authors: Emma Curran; Gary Adamson; Michael Rosato; Paul De Cock; Gerard Leavey Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2018-05-03 Impact factor: 4.328
Authors: Shefali Miller; Lisa M McTeague; Anett Gyurak; Brian Patenaude; Leanne M Williams; Stuart M Grieve; Mayuresh S Korgaonkar; Amit Etkin Journal: Depress Anxiety Date: 2015-04-27 Impact factor: 6.505